Vimarsana
Biggest News Aggregation in the World

Page 3 - Last Accessed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Last Accessed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Last Accessed Today - Breaking & Trending Today

The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paedi - Vimarsana News

The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paedi

- TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age...

GSK survey finds parents know less about meningitis compared to some other childhood diseases - Vimarsana News

GSK survey finds parents know less about meningitis compared to some other childhood diseases

Results announced today in a multi-country GSK-commissioned and funded survey conducted by Ipsos show that parents are less knowledgeable about meningitis compared to some other childhood infectious diseases. The aim of the survey was to gain an understanding of meningitis awareness and any potential gaps in ...

GSK : survey finds parents know less about meningitis compared to some other childhood diseases -October 05, 2023 at 04:05 am EDT - Vimarsana News

GSK : survey finds parents know less about meningitis compared to some other childhood diseases -October 05, 2023 at 04:05 am EDT

New multi-country survey finds 93% of parents couldn't identify all three of the most common meningitis symptoms.1 While 88% considered meningitis to be a serious...

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks o - Vimarsana News

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks o

ZURICH, Sept. 22, 2023 /PRNewswire/ -- Takeda (TSE:4502) (NYSE:TAK) today announced the European Medicines...

ACCESS Consensus Group: Experts Warn of an Increase in Cervical Cancer if Under-screened Women Are Not Prioritised - Vimarsana News

ACCESS Consensus Group: Experts Warn of an Increase in Cervical Cancer if Under-screened Women Are Not Prioritised

Screening programmes remain the most powerful tool to reduce cervical cancer rates in the near term, but there is a concerning decline in participation in some...